BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 21703011)

  • 1. Unlocking the protective potential of the angiotensin type 2 receptor (AT
    Abadir P; Cosarderelioglu C; Damarla M; Malinina A; Dikeman D; Marx R; Nader MM; Abadir M; Walston J; Neptune E
    Biochem Pharmacol; 2024 Feb; 220():115978. PubMed ID: 38081369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical Reformulation of Valsartan for Treatment of Chronic Diabetic Wounds.
    Abadir P; Hosseini S; Faghih M; Ansari A; Lay F; Smith B; Beselman A; Vuong D; Berger A; Tian J; Rini D; Keenahan K; Budman J; Inagami T; Fedarko N; Marti G; Harmon J; Walston J
    J Invest Dermatol; 2018 Feb; 138(2):434-443. PubMed ID: 29078982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in growth factor levels after thermal ablation in a murine model of colorectal liver metastases.
    Fifis T; Malcontenti-Wilson C; Amijoyo J; Anggono B; Muralidharan V; Nikfarjam M; Christophi C
    HPB (Oxford); 2011 Apr; 13(4):246-55. PubMed ID: 21418130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A chromatographic method for determining the interaction between a drug and two target proteins by fabricating a dual-heterogeneous surface.
    Qu L; Li T; Cun S; Zheng X; Xiang M; Dong Y; Ji X; Bian L; Li Q; Zhao X
    J Chromatogr A; 2024 Jan; 1715():464606. PubMed ID: 38154257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognosis of Midkine and AT1R expression in resectable head and neck squamous cell carcinoma.
    Chiu TJ; Chen CH; Chen YJ; Wee Y; Wang CS; Luo SD
    Cancer Cell Int; 2023 Sep; 23(1):212. PubMed ID: 37743493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unraveling the relationship between the renin-angiotensin system and endometrial cancer: a comprehensive review.
    Khan NA; Elsori D; Rashid G; Tamanna S; Chakraborty A; Farooqi A; Kar A; Sambyal N; Kamal MA
    Front Oncol; 2023; 13():1235418. PubMed ID: 37869088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic Variations Related to Angiotensin II Production and Risk for Basal Cell Carcinoma.
    Gintoni I; Mastrogeorgiou M; Papakosta V; Vassiliou S; Yapijakis C
    Biochem Genet; 2024 Mar; ():. PubMed ID: 38546913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the Effects of Some Cardiovascular Drugs on Angiogenesis by Transgenic Zebrafish.
    Lv H; Liu B; Qin Y
    Mediators Inflamm; 2023; 2023():1958046. PubMed ID: 37138666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective Effects of Irbesartan, an Angiotensin Receptor Blocker with PPARγ Agonistic Activity, against Estradiol Benzoate-Induced Endometrial Hyperplasia and Atypia in Female Rats via Modulation of TNFα/Survivin Pathway.
    Morsy MA; Abdelraheem WM; El-Hussieny M; Refaie MMM
    Pharmaceuticals (Basel); 2021 Jul; 14(7):. PubMed ID: 34358075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Neuropeptide System and Colorectal Cancer Liver Metastases: Mechanisms and Management.
    Kasprzak A; Adamek A
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EXPRESSION OF THE RENIN-ANGIOTENSIN SYSTEM COMPONENTS IN ONCOLOGIC DISEASES.
    Dolomatov S; Zukow W; Novikov N; Markaryan A; Eremeeva E
    Acta Clin Croat; 2019 Jun; 58(2):354-364. PubMed ID: 31819334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin I-converting enzyme inhibitors/angiotensin II receptor blockers may reduce tumor recurrence in left-sided and early colorectal cancers.
    Ozawa T; Hashiguchi Y; Yagi T; Fukushima Y; Shimada R; Hayama T; Tsuchiya T; Nozawa K; Iinuma H; Ishihara S; Matsuda K
    Int J Colorectal Dis; 2019 Oct; 34(10):1731-1739. PubMed ID: 31478086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The ACE2/Angiotensin-(1-7)/Mas Receptor Axis: Pleiotropic Roles in Cancer.
    Xu J; Fan J; Wu F; Huang Q; Guo M; Lv Z; Han J; Duan L; Hu G; Chen L; Liao T; Ma W; Tao X; Jin Y
    Front Physiol; 2017; 8():276. PubMed ID: 28533754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin II type I receptor (AT1R) is an independent prognosticator of esophageal squamous cell carcinoma and promotes cells proliferation via mTOR activation.
    Li SH; Lu HI; Chang AY; Huang WT; Lin WC; Lee CC; Tien WY; Lan YC; Tsai HT; Chen CH
    Oncotarget; 2016 Oct; 7(41):67150-67165. PubMed ID: 27564102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.
    Kast RE; Karpel-Massler G; Halatsch ME
    Oncotarget; 2014 Sep; 5(18):8052-82. PubMed ID: 25211298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse models for colorectal cancer.
    Karim BO; Huso DL
    Am J Cancer Res; 2013; 3(3):240-50. PubMed ID: 23841024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The renin angiotensin system regulates Kupffer cells in colorectal liver metastases.
    Wen SW; Ager EI; Neo J; Christophi C
    Cancer Biol Ther; 2013 Aug; 14(8):720-7. PubMed ID: 23792575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered efficacy of AT1R-targeted treatment after spontaneous cancer cell-AT1R upregulation.
    Ager EI; Wen SW; Chan J; Chong WW; Neo JH; Christophi C
    BMC Cancer; 2011 Jun; 11():274. PubMed ID: 21703011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the renin angiotensin system during the development of colorectal cancer liver metastases.
    Neo JH; Ager EI; Angus PW; Zhu J; Herath CB; Christophi C
    BMC Cancer; 2010 Apr; 10():134. PubMed ID: 20380732
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.